Tumor lysis syndrome in multiple myeloma treated with bortezomib

Dhanraj, K. M.; Biswajit, Dubashi

doi:10.4103/0976-500X.130091

Case ReportArchivesVol. 5 | Issue 2 | 2014 | pp. 161–162Open Access

Tumor lysis syndrome in multiple myeloma treated with bortezomib

¹^*,
¹

¹Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India Case Report.

Correspondence: K. M. Dhanraj
Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India Case Report.
Email: dhannu_doc@rediffmail.com

Published: Jan 1, 2014, Received: Feb 17, 2013, Accepted: Oct 6, 2013

DOI: https://doi.org/10.4103/0976-500X.130091
Article URL: https://www.jpharmacol.com/article/j-pharmacol-pharmacother-5-2-161
PDF URL: https://www.jpharmacol.com/article/j-pharmacol-pharmacother-5-2-161.pdf

Abstract

A 65 year old male diagnosed as multiple myeloma was started on bortezomib developed tumor lysis syndrome. Bortezomib induced tumor lysis is rare and suitable precautions should be considered in these patients.

Keywords

Subject

Readers Also Viewed

Original Research Article

Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models

Annisa Fatharani, Ali Alsayegh

Jan 1, 2026

Review Article

Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review

Mohammad Akbar Hossain

Jan 1, 2026

Original Research Article

Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia

Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby

Jan 1, 2026